Follow

Submissions from 2021

PDF

Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial, John Paul Diaz, Troy Gatcliffe, Zuanel Diaz, Eric Schroeder, Nicholas Lambrou, Nicole Eiseler, and Thomas Morrissey

Immunotherapy in combination with PARP inhibition in advanced cervical cancer patients functionally competent or deficient for the Fanconi anemia repair pathway, John Paul Diaz, Nicholas Lambrou, Troy Gatcliffe, and Thomas Morrissey

PDF

Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study, John Paul Diaz and Eric Schroeder

PDF

Prophylactic Negative Pressure Wound Therapy After Laparotomy for Gynecologic Surgery: A Randomized Controlled Trial, Nicholas Lambrou and John Paul Diaz

Submissions from 2020

A randomized phase II trial of secondary cytoreductive surgery (SCS) +/- carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with recurrent platinum-sensitive ovarian cancer (EOC), John Paul Diaz

PDF

Systemic Therapy for Gynecologic Malignancies, John Paul Diaz

PDF

Fertility Preservation in the Setting of Breast and Gynecologic Cancers and Cancer Treatment, John Paul Diaz and Elina Melik-Levine

Submissions from 2018

PDF

Counterpoint: Should Radiation Therapy Be Routinely Used in the Adjuvant Treatment of Stage III Endometrial Cancer?, John Paul Diaz

Submissions from 2017

PDF

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper, John Paul Diaz and Jeffrey Boyd